Similar articles

• Dysthymia and serotonin.

  Lapierre YD, Ravindran A, Bakish D. Lapierre YD, et al. Int Clin Psychopharmacol. 1993 Nov;8 Suppl 2:87-90. doi: 10.1097/00004850-199311002-00013. Int Clin Psychopharmacol. 1993. PMID: 8201250 Review. No abstract available.
• Shifting depression.

  Campbell IC, Marsden K, Powell JF. Campbell IC, et al. Psychol Med. 1994 May;24(2):271-3. doi: 10.1017/s0033291700027264. Psychol Med. 1994. PMID: 8084925 Review. No abstract available.
• [Mechanism of action of antidepressants].

  Llorca PM, Reine G, Wolf MA. Llorca PM, et al. Can J Psychiatry. 1993 Dec;38(10):649-56. doi: 10.1177/070674379303801005. Can J Psychiatry. 1993. PMID: 8313303 Review. French.
• [Is it feasible to develop a 5-HT basis for the treatment of depression?].

  Hamon M. Hamon M. Encephale. 1995 Dec;21 Spec No 4:27-32. Encephale. 1995. PMID: 8808343 Review. French. No abstract available.
• Venlafaxine: a novel antidepressant that has a dual mechanism of action.

  Andrews JM, Ninan PT, Nemeroff CB. Andrews JM, et al. Depression. 1996;4(2):48-56. doi: 10.1002/(SICI)1522-7162(1996)4:2<48::AID-DEPR2>3.0.CO;2-B. Depression. 1996. PMID: 9160640 Review.